Shuttle Pharmaceuticals (SHPH) Revenue & Revenue Breakdown
Shuttle Pharmaceuticals Revenue Highlights
00
Shuttle Pharmaceuticals Revenue by Period
Shuttle Pharmaceuticals Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | - | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2017-12-31 | - | - |
Shuttle Pharmaceuticals generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Shuttle Pharmaceuticals Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-03-31 | - | -100.00% |
| 2024-12-31 | $5.75K | 100.00% |
| 2024-09-30 | - | 100.00% |
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | -100.00% |
| 2023-12-31 | $9.66K | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | - |
Shuttle Pharmaceuticals generated - in revenue during Q1 2025, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Shuttle Pharmaceuticals Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| INM | InMed Pharmaceuticals | $4.94B | $1.26B |
| VERO | Venus Concept | $64.83M | $13.64M |
| ISPC | iSpecimen | $9.29M | $1.06M |
| RDHL | RedHill Biopharma | $6.51M | $1.80M |
| HSCS | HeartSciences | $18.60K | $1.90M |
| KZIA | Kazia Therapeutics | $555.00 | $5.00 |
| SHPH | Shuttle Pharmaceuticals | - | - |
| GCTK | GlucoTrack | - | - |
| WINT | Windtree Therapeutics | - | - |